An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis

Xiaobing Wang(Shanghai Changzheng Hospital), Huji Xu(University of Science and Technology of China), Lie Dai(Sun Yat-sen University), Jiapan Hu(Hangzhou DAC Biotech (China)), Lina Zhou(University of North Carolina at Charlotte), Xinyu Wu(Heilongjiang University of Chinese Medicine), Lin Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yixuan Zhou(Hangzhou DAC Biotech (China)), Le‐Hang Guo(Tongji University), Kun Pang(Bengbu Medical College), Xin Ma(First Affiliated Hospital of Henan University of Science and Technology), Ran Yan(Sir Run Run Shaw Hospital), Yanan Yue(Hangzhou DAC Biotech (China)), T. Y. Guan(Shanghai Changzheng Hospital), Siyuan Ye(Shanghai Changzheng Hospital), Xiaofei Shi(First Affiliated Hospital of Henan University of Science and Technology), Xin Liu(Xi'an Jiaotong University), Yi Zhang(Tianjin Medical University General Hospital), Qing Wang(Focused Photonics (China)), Yue Chen(Wenzhou Medical University), Ling Zhou(Yibin University), Yanfang Liu(Second Military Medical University), Jiazheng Wang(Shanghai Changzheng Hospital), Yi Jin(China Pharmaceutical University), Xiaobin Song(Tongji University), Ping Wang(Feinstein Institute for Medical Research), Yanran He(University of Chicago), Luhan Yang(Hangzhou DAC Biotech (China)), Wenjing Ye(Huashan Hospital), Ting Li(Zhejiang Chinese Medical University), Xiaofang Zhu(Wenzhou Medical University), Yingyong Xu(Hangzhou DAC Biotech (China)), Weihua Pan(North China Electric Power University)
Cited by 61


Related Papers